| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10130580 | AZURITY | Taste-masked pharmaceutical compositions |
Apr, 2024
(15 hours ago) | |
| US11160772 | AZURITY | Oral amphetamine composition |
Mar, 2037
(12 years from now) | |
| US10441554 | AZURITY | Oral amphetamine composition |
Mar, 2037
(12 years from now) | |
Evekeo Odt is owned by Azurity.
Evekeo Odt contains Amphetamine Sulfate.
Evekeo Odt has a total of 3 drug patents out of which 1 drug patent has expired.
Expired drug patents of Evekeo Odt are:
- US10130580
Evekeo Odt was authorised for market use on 16 April, 2021.
Evekeo Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Evekeo Odt are possible to be released after 10 March, 2037.
Drugs and Companies using AMPHETAMINE SULFATE ingredient
Market Authorisation Date: 16 April, 2021
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
EVEKEO ODT family patents
